Choroidal neovascularisation in pathological myopia: an update in management.
Choroidal neovascularisation (CNV) secondary to pathological myopia is an important cause of significant visual impairment in young and middle aged adults globally and is particularly prevalent in Asian populations. In the past few years, there have been rapid advancements in the different treatments for myopic CNV. The purpose of this perspective is to give an overview of the natural history of myopic CNV and the various treatment options including laser photocoagulation, photodynamic therapy, sub-macular surgery, and macular translocation surgery. Future directions in the management of myopic CNV are also discussed.
Chan
W-M
WM
Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, 3/F, Hong Kong Eye Hospital, Kowloon, Hong Kong. cwm6373@netvigator.com
Ohji
M
M
Lai
T Y Y
TY
Liu
D T L
DT
Tano
Y
Y
Lam
D S C
DS
D020256:Choroidal Neovascularization / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy*; D006801:Humans; D017075:Laser Coagulation; D008266:Macula Lutea / Q000601:surgery; D047728:Myopia, Degenerative / Q000150:complications*; D010778:Photochemotherapy